SNDA vs SGRY

For growth investors, Sonida Senior Living, Inc.

(SNDA) is the stronger pick with 25. 2% revenue growth year-over-year, versus 6. 2% for Surgery Partners, Inc. (SGRY). Analysts rate Surgery Partners, Inc. (SGRY) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Sonida Senior Living, Inc.

(SNDA) delivered a total return of -17. 2%, compared to -71. 9% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: SGRY returned +4. 9% versus SNDA's -87. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Surgery Partners, Inc.

(SGRY) is the lower-risk stock at 1. 04β versus Sonida Senior Living, Inc. 's 1. 10β — meaning SNDA is approximately 5% more volatile than SGRY relative to the S&P 500. On balance sheet safety, Surgery Partners, Inc. (SGRY) carries a lower debt/equity ratio of 114% versus 12% for Sonida Senior Living, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sonida Senior Living, Inc.

(SNDA) is pulling ahead at 25. 2% versus 6. 2% for Surgery Partners, Inc. (SGRY). On earnings-per-share growth, the picture is similar: Surgery Partners, Inc. grew EPS 54. 1% year-over-year, compared to -681. 5% for Sonida Senior Living, Inc.. Over a 3-year CAGR, SNDA leads at 16. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Surgery Partners, Inc.

(SGRY) is the more profitable company, earning -2. 4% net margin versus -20. 0% for Sonida Senior Living, Inc. — meaning it keeps -2. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGRY leads at 11. 8% versus -15. 3% for SNDA. At the gross margin level — before operating expenses — SGRY leads at 23. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for SGRY: 27.

5% to $18. 60.

In this comparison, SNDA (0.

8% yield) pays a dividend. SGRY does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Sonida Senior Living, Inc.

(SNDA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 10), 0. 8% yield). Both have compounded well over 10 years (SNDA: -87. 5%, SGRY: +4. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SNDA is a small-cap high-growth stock; SGRY is a small-cap quality compounder stock. SNDA pays a dividend while SGRY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.